Physician profile
April Turner
NPI 1629043864
$730.24
in general payments reported to CMS, 2019-2025
17 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.77 · 2021: $116 · 2022: $202 · 2023: $146 · 2024: $91.35 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $217.18 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $81.15 | 2022 | |
| Glaxosmithkline, LLC. | $67.20 | 2021-2023 | Arexvy, Shingrix |
| Corcept Therapeutics | $38.57 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.52 | 2020-2025 | Jardiance |
| Tolmar Pharmaceuticals, INC. | $36.80 | 2021 | |
| Sumitomo Pharma America, INC. | $33.82 | 2025 | Gemtesa |
| Novo Nordisk INC | $31.22 | 2025 | Wegovy, Rybelsus, Ozempic |
| Abiomed | $26.23 | 2023 | Impella |
| Astrazeneca Pharmaceuticals LP | $25.40 | 2025 | Airsupra |
| E.R. Squibb & Sons, L.L.C. | $24.71 | 2024 | Eliquis |
| Depuy Synthes Sales INC. | $20.72 | 2024 | Orthovisc, Monovisc |
| Abbvie INC. | $19.96 | 2022 | |
| Exact Sciences Corporation | $19.74 | 2025 | Cologuard Collection Kit |
| Bioventus LLC | $18.44 | 2023 | Supartz Fx Sodium Hyaluronate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.19 | 2025 | Jardiance |
| Hikma Pharmaceuticals USA | $14.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.